Cite

HARVARD Citation

    Abudurexiti, M. et al. (2020). Targeting CPT1B as a potential therapeutic strategy in castration‐resistant and enzalutamide‐resistant prostate cancer. Prostate. 80 (12), pp. 950-961. [Online]. 
  
Back to record